Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Eli lilly and company crawled time : 22:00 save search
Usher Syndrome Market to Exhibit Growth at a CAGR of 10.55% by 2034 | DelveInsight
Published: 2024-04-11 (Crawled : 22:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -8.65%
H: 3.19%
C: 1.6%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.65%
H: 0.0%
C: 0.0%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.0%
H: 0.52%
C: -1.04%
growth market
Blacksmith Medicines To Highlight Preclinical Oncology Data Demonstrating a Potent and Selective FEN1 Inhibitor Has Synergy with Multiple DDR Drug Classes at AACR Annual Meeting 2024
Published: 2024-04-10 (Crawled : 22:00) - biospace.com/
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.71%
H: 0.0%
C: 0.0%
drug preclinical meeting
Global Tissue Banking Market to Exhibit Growth at a Considerable CAGR of ~6% by 2030, Assesses DelveInsight
Published: 2024-04-09 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: -2.01%
H: 0.0%
C: 0.0%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.71%
H: 0.0%
C: 0.0%
BIO | News | $279.73 -0.46% 0.0% 290K
|
Health Technology
|
| O: -2.71%
H: 0.52%
C: 0.24%
AVTR | $24.1 -0.82% 0.25% 4.7M
|
Process Industries
|
| O: -1.7%
H: 1.08%
C: 0.55%
THMO | $0.6695 3.0% 2.91% 8.6K
|
Health Technology
|
| O: 4.99%
H: 2.78%
C: -2.1%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
global growth market
Giant-Cell Arteritis Market to Showcase Positive Growth at a CAGR of 9.3% by 2034 | DelveInsight
Published: 2024-04-08 (Crawled : 22:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.05%
H: 0.02%
C: -2.62%
MOR | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 0.06%
H: 0.22%
C: 0.0%
KNSA | $16.93 0.3% 0.3% 380K
|
Health Technology
|
| O: 0.23%
H: 1.58%
C: 0.06%
IMAB | $1.81 0.56% 0.55% 340K
|
Health Technology
|
| O: -0.55%
H: 1.39%
C: 0.0%
GLPG | $29.095 0.64% 0.64% 87K
|
Health Technology
|
| O: 0.0%
H: 0.39%
C: -0.66%
positive growth market
Lilly Announces Details of Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting
Published: 2024-03-05 (Crawled : 22:00) - prnewswire.com
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.86%
H: 0.45%
C: -0.58%
association cancer research meeting
Proniras Corporation Secures New Series B Financing and Names New Board Members to Support Phase 1 Study of Novel Treatment for Opiate Withdrawal
Published: 2024-02-01 (Crawled : 22:00) - biospace.com/
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.27%
H: 2.04%
C: 2.02%
corporation series treatment study
Colposcopy Devices Global Market Likely to Exhibit Substantial Growth at a CAGR of ~5% by 2028, Predicts DelveInsight
Published: 2024-01-26 (Crawled : 22:00) - prnewswire.com
PHG | $19.98 0.0% 540K
|
Health Technology
| Email alert
Add to watchlist
EVFM | $0.0141 -16.94% 180K
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
| Email alert
Add to watchlist
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
| Email alert
Add to watchlist
PKX | News | $70.59 0.7% 0.0% 73K
|
Non-Energy Minerals
| Email alert
Add to watchlist
global growth market
Vanda Pharmaceuticals announces the publication of an article on The Efficacy of Tradipitant in Patients with Diabetic and Idiopathic Gastroparesis in Phase III Randomized Placebo-Controlled Clinical Trial
Published: 2024-01-25 (Crawled : 22:00) - biospace.com/
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -1.0%
H: 0.84%
C: 0.04%
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: 2.72%
H: 0.53%
C: 0.53%
publication pharmaceuticals trial diabetic
Drug-Eluting Balloons Global Market is Expected to Expand at a Healthy Growth Rate of ~8% by 2028, Predicts DelveInsight
Published: 2024-01-24 (Crawled : 22:00) - prnewswire.com
TRUMF | $16.928 -17.59% 1.9K
|
Health Technology
|
| O: 3.54%
H: 0.0%
C: 0.0%
TRUMY | $16.507 0.79% 34K
|
Manufacturing
|
| O: -0.3%
H: 0.18%
C: -0.06%
PHG | $19.98 0.0% 540K
|
Health Technology
|
| O: 0.0%
H: 0.57%
C: 0.48%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -1.0%
H: 0.84%
C: 0.04%
BSX | $67.33 -0.13% -0.31% 7M
|
Health Technology
|
| O: 0.58%
H: 0.98%
C: 0.93%
SRDX | $26.47 0.3% 0.3% 55K
|
Health Technology
|
| O: 1.03%
H: 0.0%
C: -1.34%
expected global growth market
CAR T-Cell Therapy Market to Register Stunning Growth During the Study Period (2019-2032) | DelveInsight
Published: 2024-01-23 (Crawled : 22:00) - prnewswire.com
ACLX | $51.67 -5.19% -5.48% 740K
|
|
| O: 1.59%
H: 1.14%
C: -1.42%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.61%
H: 1.52%
C: 0.03%
PSTX | News | $2.02 1.0% 0.99% 640K
|
Health Technology
|
| O: 1.57%
H: 4.94%
C: 1.54%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.29%
H: 0.15%
C: -1.95%
BEAM | $23.9 -1.69% -1.72% 4.5M
|
Health Technology
|
| O: 1.88%
H: 0.88%
C: -2.79%
t-cell therapy growth study market
Non-Alcoholic Fatty Liver Disease Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key Companies - MediciNova, Eli Lilly and Company, AstraZeneca, Madrigal Pharmaceuticals, BioMarin Pharmaceutical, GlaxoSmithKline, Pfizer
Published: 2024-01-22 (Crawled : 22:00) - prnewswire.com
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.51%
H: 0.37%
C: 0.32%
MDGL | $212.33 -4.47% -4.68% 620K
|
Health Technology
|
| O: 1.29%
H: 0.35%
C: -3.04%
HEPA | $2.11 -0.09% -0.09% 73K
|
Health Technology
|
| O: -0.48%
H: 7.69%
C: 1.44%
ALT | $6.91 0.29% 0.29% 3.6M
|
Commercial Services
|
| O: -0.8%
H: 6.02%
C: 0.6%
ALNY | News | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: 0.46%
H: 3.04%
C: 2.67%
ETNB | $9.08 2.25% 2.2% 1M
|
Health Technology
|
| O: 1.19%
H: 0.63%
C: -0.72%
liver disease companies key growth market
AAV Vectors in Gene Therapy Market is Predicted to Observe Skyrocketed Growth During the Study Period (2019-2032) | DelveInsight `
Published: 2024-01-16 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.83%
H: 0.0%
C: 0.0%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.77%
H: 0.17%
C: -1.65%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.45%
H: 0.06%
C: -0.5%
RGNX | $15.67 -2.73% -2.87% 570K
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: -7.15%
ADVM | $11.34 1.7% 1.68% 140K
|
Health Technology
|
| O: -0.69%
H: 2.32%
C: -0.12%
therapy growth study market
Sjogren's Syndrome Market to Register Sustainable Growth During the Study Period (2019-2032), Predicts DelveInsight | Key Players - Horizon Therapeutics, Dompe Farmaceutici, MorphoSys, Resolve Therapeutics, Novartis, Johnson & Johnson
Published: 2024-01-16 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.83%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.77%
H: 0.17%
C: -1.65%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.45%
H: 0.06%
C: -0.5%
IMAB | $1.81 0.56% 0.55% 340K
|
Health Technology
|
| O: -1.08%
H: 0.0%
C: -8.42%
resolve key growth study market
Heart Failure Treatment Drug Market to Accelerate Immensely by 2032, Predicts DelveInsight
Published: 2024-01-15 (Crawled : 22:00) - prnewswire.com
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.15%
H: 0.59%
C: -1.45%
drug treatment heart market
Gene Therapy Global Market is Projected to Grow at a CAGR of ~19% by 2028, Predicts DelveInsight
Published: 2024-01-12 (Crawled : 22:00) - prnewswire.com
TGTX | News | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
| Email alert
Add to watchlist
VRTX | News | $394.43 0.24% 0.24% 1.3M
|
Health Technology
| Email alert
Add to watchlist
RARE F | $42.37 -2.33% -2.38% 680K
|
Health Technology
| Email alert
Add to watchlist
SLDB | $8.7 -6.05% -6.44% 110K
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
| Email alert
Add to watchlist
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
BLUE | $1.02 7.03% 6.11% 8.2M
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
DTIL | $9.75 -9.05% -9.95% 170K
|
Health Technology
| Email alert
Add to watchlist
global therapy market
Gastroenteropancreatic Neuroendocrine Tumors Market to Showcase a Significant Growth by 2032, Evaluates DelveInsight | Key Players - Eli Lilly and Company, Phanes Therapeutics, Camurus AB, Advanced Accelerator Applications, PharmaMar
Published: 2024-01-11 (Crawled : 22:00) - prnewswire.com
RYZB | $62.49 0.03% 280K
|
|
| O: 0.21%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.71%
H: 0.0%
C: 0.0%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.39%
H: 0.91%
C: 0.74%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.06%
H: 0.0%
C: 0.0%
tumors key advanced growth market
Focal Segmental Glomerulosclerosis Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Leading Companies - ACELYRIN, Genentech, ChemoCentryx, Travere Therapeutics, Boehringer Ingelheim, Chinook Therapeutics
Published: 2024-01-10 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.1%
H: 0.0%
C: 0.0%
NVO | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.33%
H: 0.35%
C: -1.5%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.67%
H: 0.85%
C: 0.21%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
ALDX | News | $3.865 -2.89% -2.98% 430K
|
Health Technology
|
| O: -1.8%
H: 0.46%
C: -2.44%
companies therapeutics growth market
Lilly to Participate in J.P. Morgan Healthcare Conference - January 2, 2024
Published: 2024-01-02 (Crawled : 22:00) - biospace.com/
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.43%
H: 2.12%
C: 2.03%
conference
Metastatic Castration-Resistant Prostate Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 7.5% During the Study Period (2019-2032), Estimates DelveInsight
Published: 2023-12-20 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.87%
H: 0.0%
C: 0.0%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.21%
H: 0.63%
C: 0.1%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
cancer growth study market
Metastatic Prostate Cancer Market to Exhibit Positive Growth at a CAGR of 22% and 7.5% for mHSPC and mCRPC, respectively During the Study Period (2019-2032), Assesses DelveInsight
Published: 2023-12-13 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: 0.0%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 1.8%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
positive cancer growth study market
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.